Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement
Open accessAbstract
Patients undergoing evaluation for solid organ transplantation (SOT) often have a history of malignancy. Although the cancer has been treated in these patients, the benefits of transplantation need to be balanced against the risk of tumor recurrence, especially in the setting of immunosuppression. Prior guidelines of when to transplant patients with a prior treated malignancy do not take in to account current staging, disease biology, or advances in cancer treatments. To develop contemporary recommendations, the American Society of Transplantation held a consensus workshop to perform a comprehensive review of current literature regarding cancer therapies, cancer stage-specific prognosis, the kinetics of cancer recurrence, and the limited data on the effects of immunosuppression on cancer-specific outcomes. This document contains prognosis based on contemporary treatment and transplant recommendations for breast, colorectal, anal, urological, gynecological, and nonsmall cell lung cancers. This conference and consensus documents aim to provide recommendations to assist in the evaluation of patients for SOT given a history of a pretransplant malignancy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Transplantation may be considered in patients with carcinoma not significantly affected by immunosuppressants.
“in patients with carcinoma not significantly affected by immunosuppressants”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [6]
The Breast Cancer and Gynecologic Cancers transplant-recommendation sections (pages unavailable) say that selected patients with low-risk, treated cancers may be considered for transplantation. The Introduction does not establish that their carcinomas are unaffected by immunosuppression; it identifies increased recurrence risk as a concern and says evidence on safety in patients with pretransplant malignancy is limited. (LLM, conf=0.84)
Experimental — accuracy not yet measuredTransplantation may be considered in patients with a previous cancer history who are well-maintained and without recurrence for more than 5 years.
“transplantation may be considered in patients with a previous cancer history who are well-maintained and without recurrence for more than 5 years”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [6]
The Colorectal Cancer and Gynecologic Cancers transplant-recommendation sections say that some patients with treated cancer and no recurrence may be considered for transplantation, including after disease-free intervals of 3–5 years. The paper does not give more than five years without recurrence as a general criterion for all previous cancers: recommendations vary by cancer and risk, and the Breast Cancer recommendations say some patients generally should not be candidates. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measuredTransplantation should be avoided if a metastatic lesion is present, there is a high risk of recurrence, or the patient's life expectancy is short.
“transplantation should be avoided if a metastatic lesion is present, there is a high risk of recurrence, or the patient’s life expectancy is short [6,7].”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [6]
The Breast Cancer transplant recommendations (page not provided) say patients with metastatic disease and poor survival generally should not be considered for transplantation. But the Gynecologic Cancers recommendations allow consideration of high-risk patients after 3–5 years without recurrence, and the Colorectal Cancer recommendations allow transplantation for selected patients with liver metastases. The claim overstates these conditional recommendations as a blanket rule. (LLM, conf=0.86)
Experimental — accuracy not yet measuredTransplantation may be considered in patients who have no metastasis and a very low risk of recurrence.
“in those who have no metastasis and a very low risk of recurrence”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160 · see citing works
(2016) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,280 · see citing works
Siegel, R. L., Miller, K. D., & Jemal, A. (2018) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21442 · Cited by 16,632 · see citing works
Amin, M. B., Greene, F. L., Edge, S. B., Compton, C. C., Gershenwald, J. E., Brookland, R. K., Meyer, L., Gress, D. M., Byrd, D. R., & Winchester, D. P. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21388 · Cited by 6,531 · see citing works
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784 · cited 1× · see citing works
“73 For women with cervical cancer, surgery is reserved for those without evidence of bulky cervical disease (primary cervical lesion 4 cm or larger) or other advanced features (eg, local invasion beyond the uterus).”
BackgroundSelf-citationCancer treatment and survivorship statistics, 2019
Miller, K. D., Nogueira, L., Mariotto, A. B., Rowland, J. H., Yabroff, K. R., Alfano, C. M., Jemal, A., Kramer, J. L., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21565 · Cited by 4,253 · see citing works
Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients
Stein, J. P., Lieskovsky, G., Cote, R., Groshen, S. G., Feng, A., Boyd, S. D., Skinner, E. C., Bochner, B. H., Thangathurai, D., Mikhail, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.666 · Cited by 3,527 · see citing works
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Moore, K., Colombo, N., Scambia, G., Kim, B.-G., Oaknin, A., Friedlander, M., Lisyanskaya, A., Floquet, A., Leary, A., Sonke, G. S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1810858 · Cited by 2,870 · see citing works
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
Hamdy, F. C., Donovan, J., Lane, J. A., Mason, M. D., Metcalfe, C. D., Holding, P., Davis, M., Peters, T. J., Turner, E. L., Martin, R. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606220 · Cited by 2,642 · see citing works
Two pathogenetic types of endometrial carcinoma
Bokhman, J. V. (1983) · Gynecologic Oncology · doi:10.1016/0090-8258(83)90111-7 · Cited by 2,508 · see citing works
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D. F., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Goetz, M. P., Olson, J. A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1804710 · Cited by 2,397 · see citing works
Peters, W. A., Liu, P. Y., Barrett, R. J., Stock, R. J., Monk, B. J., Berek, J. S., Souhami, L., Grigsby, P. W., Gordon, W., & Alberts, D. S. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1606 · Cited by 2,288 · see citing works
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
González-Martı́n, A., Pothuri, B., Vergote, I. B., Christensen, R. D., Graybill, W. A. S., Mirza, M. R., McCormick, C., Lorusso, D., Hoskins, P. J., Freyer, G., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910962 · Cited by 2,278 · see citing works
Molecular Basis of Colorectal Cancer
Markowitz, S. D., & Bertagnolli, M. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804588 · Cited by 2,052 · see citing works
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Cardoso, F., Veer, L. J. V., Bogaerts, J., Slaets, L., Viale, G., Delaloge, S., Pierga, J., Brain, E. G. C., Causeret, S., Delorenzi, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602253 · Cited by 1,998 · see citing works
Kuipers, E. J., Grady, W. M., Lieberman, D. A., Seufferlein, T. T. W., Sung, J. J. �., Boelens, P. G., van de Velde, C. J. �., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,683 · see citing works
Spectrum of cancer risk among US solid organ transplant recipients
Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., et al. (2011) · JAMA · doi:10.1001/jama.2011.1592 · Cited by 1,524 · see citing works
Treatment of Stage I and II Non-small Cell Lung Cancer
Howington, J. A., Blum, M. G., Chang, A. C., et al. (2013) · CHEST Journal · doi:10.1378/chest.12-2359 · Cited by 1,441 · see citing works
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
Sparano, J. A., Gray, R. J., Makower, D., Pritchard, K. I., Albain, K. S., Hayes, D. F., Geyer, C. E., Dees, E. C., Perez, E. A., Olson, J. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510764 · Cited by 1,386 · see citing works
Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329 · see citing works
Sedlis, A., Bundy, B. N., Rotman, M. Z., Lentz, S. S., Muderspach, L. I., & Zaino, R. J. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1999.5387 · Cited by 1,318 · see citing works
Giuliano, A. E., Connolly, J. L., Edge, S. B., Mittendorf, E. A., Rugo, H. S., Solin, L. J., Weaver, D. L., Winchester, D. J., & Hortobágyi, G. N. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21393 · Cited by 974 · see citing works
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D. A., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 943 · see citing works
The evaluation of renal transplantation candidates: clinical practice guidelines.
Kasiske, B. L., Cangro, C. B., Hariharan, S., et al. (2001) · PubMed · Cited by 726 · see citing works
Hance, K. W., Anderson, W. F., Devesa, S. S., Young, H. A., & Levine, P. H. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji172 · Cited by 687 · see citing works
Tie, J., Cohen, J. D., Wang, Y., Christie, M., Simons, K., Lee, M., Wong, R., Kosmider, S., Ananda, S., McKendrick, J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.3616 · Cited by 668 · see citing works
Smith, J. J., Strombom, P. D., Chow, O. S., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.5896 · Cited by 589 · see citing works
Oddens, J. R., Brausi, M. A., Sylvester, R. J., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.10.039 · Cited by 519 · see citing works
Dawood, S. S., Merajver, S. D., Viens, P., Vermeulen, P. B., Swain, S. M., Buchholz, T. A., Dirix, L. Y., Levine, P. H., Lucci, A., Krishnamurthy, S., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq345 · Cited by 490 · see citing works
Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer
Matei, D. E., Filiaci, V. L., Randall, M. E., Mutch, D. G., Steinhoff, M. M., DiSilvestro, P., Moxley, K. M., Kim, Y. M., Powell, M. A., O’Malley, D. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813181 · Cited by 476 · see citing works
Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer
Hagness, M., Foss, A. E., Line, P., Scholz, T., Jørgensen, P. F., Fosby, B., Boberg, K. M., Mathisen, Ø., Gladhaug, I. P., Egge, T. S., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182823957 · Cited by 464 · see citing works
Sylvester, R. J., Brausi, M. A., Kirkels, W. J., et al. (2009) · European Urology · doi:10.1016/j.eururo.2009.12.024 · Cited by 441 · see citing works
Treatment of Stage III Non-small Cell Lung Cancer
Ramnath, N., Dilling, T. J., Harris, L. J., Kim, A. W., Michaud, G. C., Balekian, A. A., Diekemper, R. L., Detterbeck, F. C., & Arenberg, D. A. (2013) · CHEST Journal · doi:10.1378/chest.12-2360 · Cited by 440 · see citing works
Patard, J., Kim, H. L., Lam, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.104 · Cited by 423 · see citing works
Dueland, S., Syversveen, T., Solheim, J. M., Solberg, S. K., Grut, H., Bjørnbeth, B. A., Hagness, M., & Line, P. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003404 · Cited by 367 · see citing works
Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline
Finelli, A., Ismaila, N., Bro, B., Durack, J. C., Eggener, S. E., Evans, A. J., Gill, I. S., Graham, D. L., Huang, W. C. W., Jewett, M. A. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.9645 · Cited by 365 · see citing works
Self-citationWright, A. A., Bohlke, K., Armstrong, D. K., et al. (2016) · Gynecologic Oncology · doi:10.1016/j.ygyno.2016.05.022 · Cited by 361 · see citing works
THE EFFECT OF IMMUNOSUPPRESSION ON PRE-EXISTING CANCERS
Penn, I. (1993) · Transplantation · doi:10.1097/00007890-199304000-00011 · Cited by 343 · see citing works
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer
Abdel-Qadir, H. M., Austin, P. C., Lee, D. S., Amir, E., Tu, J. V., Thavendiranathan, P., Fung, K., & Anderson, G. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3841 · Cited by 313 · see citing works
Abdel-Wahab, N., Safa, H., Abudayyeh, A., Johnson, D. H., Trinh, V. A., Zobniw, C. M., Lin, H., Wong, M. K., Abdelrahim, M., Gaber, A. O., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0585-1 · Cited by 294 · see citing works
Kobayashi, H., Mochizuki, H., Sugihara, K., Morita, T., Kotake, K., Teramoto, T., Kameoka, S., Saitō, Y., Takahashi, K., Hase, K., et al. (2006) · Surgery · doi:10.1016/j.surg.2006.07.020 · Cited by 282 · see citing works
Chemoradiotherapy for Cervical Cancer Meta‐analysis Collaboration (CCCMAC) (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008285 · Cited by 275 · see citing works
Zlotta, A. R., Egawa, S., DIu, P., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt151 · Cited by 258 · see citing works
Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · JAMA · doi:10.1001/jama.2017.7630 · Cited by 242 · see citing works
Lobbezoo, D. J. A., van Kampen, R. J. W., Voogd, A. C., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.127 · Cited by 229 · see citing works
Weiss, A. C., Chávez‐MacGregor, M., Lichtensztajn, D. Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.4298 · Cited by 229 · see citing works
Zhang, Y., Schnabel, C. A., Schroeder, B. E., Jerevall, P.-L., Jankowitz, R. C., Fornander, T., Stål, O., Brufsky, A., Sgroi, D. C., & Erlander, M. G. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0804 · Cited by 226 · see citing works
Wang, Y., Li, L., Cohen, J. D., Kinde, I., Ptak, J., Popoli, M., Schaefer, J., Silliman, N., Dobbyn, L., Tie, J., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.0512 · Cited by 226 · see citing works
Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer
Taylor, M. D., Nagji, A. S., Bhamidipati, C. M., Theodosakis, N., Kozower, B. D., Lau, C. L., & Jones, D. R. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.03.031 · Cited by 219 · see citing works
Clamp, A. R., James, E. C., McNeish, I. A., Dean, A. P., Kim, J., O’Donnell, D. M., Hook, J., Coyle, C., Blagden, S. P., Brenton, J. D., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32259-7 · Cited by 210 · see citing works
Evaluation of transplant candidates with pre-existing malignancies.
Penn, I. (1997) · PubMed · Cited by 200 · see citing works
Stephenson, A. J., CHETNER, M. P., Rourke, K. F., et al. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000132126.85812.7d · Cited by 195 · see citing works
Nordness, M. F., Hamel, S., Godfrey, C. M., Shi, C., Johnson, D. B., Goff, L. W., O’Dell, H., Perri, R. E., & Alexopoulos, S. P. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15617 · Cited by 169 · see citing works
Anal cancer and intraepithelial neoplasia screening: A review
Leeds, I. L. (2016) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v8.i1.41 · Cited by 162 · see citing works
Fisher, J., Zeitouni, N. C., Fan, W., & Samie, F. H. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2019.07.005 · Cited by 157 · see citing works
Bhindi, B., Thompson, R. H., Lohse, C. M., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.06.003 · Cited by 152 · see citing works
Kiely, B. E., Soon, Y. Y., Tattersall, M. H. N., & Stockler, M. R. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2174 · Cited by 135 · see citing works
Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved
Toso, C., Marques, H. P., Andrès, A., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24791 · Cited by 134 · see citing works
The risk of second primary tumors after resection of stage I nonsmall cell lung cancer
Rice, D. C., Kim, H.-W., Sabichi, A. L., Lippman, S. M., Lee, J. J., Williams, B., Vaporciyan, A. A., Smythe, W. R., Swisher, S. G., Walsh, G. L., et al. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00821-x · Cited by 126 · see citing works
Snyder, R. A., Hu, C., Cuddy, A., Francescatti, A. B., Schumacher, J. R., Loon, K. V., You, Y. N., Kozower, B. D., Greenberg, C. C., Schrag, D., et al. (2018) · JAMA · doi:10.1001/jama.2018.5816 · Cited by 112 · see citing works
Self-citationSoukup, V., Čapoun, O., Cohen, D. L., Hernández, V., Burger, M., Compérat, É., Gontero, P., Lam, T. B. L., Mostafid, H. A., Palou, J., et al. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.11.005 · Cited by 107 · see citing works
Inflammatory breast cancer: a proposed conceptual shift in the UICC–AJCC TNM staging system
Fouad, T. M., Gutierrez‐Barrera, A. M., Reuben, J. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30192-4 · Cited by 95 · see citing works
Sonpavde, G., Khan, M. M., Lerner, S. P., Svatek, R. S., Novara, G., Karakiewicz, P. I., Skinner, E. C., Derya Tilki, A., Kassouf, W., Fradet, Y., et al. (2010) · The Journal of Urology · doi:10.1016/j.juro.2010.09.110 · Cited by 94 · see citing works
Natural History of Complex Renal Cysts: Clinical Evidence Supporting Active Surveillance
Chandrasekar, T., Ahmad, A. E., Fadaak, K., et al. (2017) · The Journal of Urology · doi:10.1016/j.juro.2017.09.078 · Cited by 94 · see citing works
Metastatic potential of a renal mass according to original tumour size at presentation
Umbreit, E. C., Shimko, M. S., Childs, M. A., et al. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10184.x · Cited by 93 · see citing works
Multidrug resistance in ovarian cancer
Fojo, A. T., Hamilton, T. C., Young, R. C., & Ozols, R. F. (1987) · Cancer · doi:10.1002/1097-0142(19901015)60:8+ · Cited by 93 · see citing works
Implications for Breast Cancer Restaging Based on the 8th Edition AJCC Staging Manual
Plichta, J. K., Ren, Y., Thomas, S. M., Greenup, R. A., Fayanju, O. M., Rosenberger, L. H., Hyslop, T., & Hwang, E. S. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000003071 · Cited by 90 · see citing works
Self-citationFifteen-year trends in metastatic breast cancer survival in Greece
Dafni, U. G., Grimani, I., Xyrafas, A., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0630-8 · Cited by 86 · see citing works
Brattström, C., Granath, F. N., Edgren, G., Smedby, K. E. E., & Wilczek, H. (2013) · Transplantation · doi:10.1097/tp.0b013e31829854b7 · Cited by 86 · see citing works
Competing Causes of Death for Women With Breast Cancer and Change Over Time From 1975 to 2003
Du, X. L., Fox, E. E., & Lai, D. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318142c865 · Cited by 73 · see citing works
Boissier, R., Hevia, V., Bruins, H. M., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.07.017 · Cited by 67 · see citing works
Verstegen, N. E., Lagerwaard, F. J., Hashemi, S. M. S., Dahele, M. R., Slotman, B. J., & Senan, S. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000576 · Cited by 58 · see citing works
Solid Organ Transplantation in Patients With Preexisting Malignancies in Remission
Acuña, S. A., Sutradhar, R., Kim, S. J., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002178 · Cited by 58 · see citing works
Cancer recurrence after solid organ transplantation: A systematic review and meta-analysis
Acuña, S. A., Huang, J. W., Dossa, F., et al. (2017) · Transplantation Reviews · doi:10.1016/j.trre.2017.08.003 · Cited by 56 · see citing works
Radiographic Response and Clinical Toxicity Following SBRT for Stage I Lung Cancer
Bradley, J. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318074e50c · Cited by 54 · see citing works
Prognosis of recurrent non-small cell lung cancer following complete resection
Sasaki, H., Suzuki, A., Tatematsu, T., Shitara, M., Hikosaka, Y., Okuda, K., Moriyama, S., Yano, M., & Fujii, Y. (2014) · Oncology Letters · doi:10.3892/ol.2014.1861 · Cited by 51 · see citing works
Prevalence and outcome of lung cancer in lung transplant recipients
Grewal, A. S., Padera, R. F., Boukedes, S. S., Divo, M. J., Rosas, I. O., Camp, P. C., Fuhlbrigge, A. L., Goldberg, H. J., & El‐Chemaly, S. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2014.12.013 · Cited by 49 · see citing works
Noone, A., Pfeiffer, R. M., Dorgan, J. F., Magder, L. S., Bromberg, J. S., Lynch, C. F., Morris, C. R., Pawlish, K. S., & Engels, E. A. (2019) · Cancer · doi:10.1002/cncr.32136 · Cited by 45 · see citing works
Califano, R., Gomes, F., Ackermann, C. J., Rafee, S., Tsakonas, G., & Ekman, S. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.11.010 · Cited by 42 · see citing works
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis
Liauw, S. L., Ham, S. A., Das, L. C., Rudra, S., Packiam, V. T., Koshy, M., Weichselbaum, R. R., Becker, Y. T., Bodzin, A. S., & Eggener, S. E. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz221 · Cited by 41 · see citing works
Self-citationSuardi, N. R., Dell’Oglio, P., Gallina, A., et al. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.08.019 · Cited by 37 · see citing works
Livingston‐Rosanoff, D., Foley, D. P., LEVERSON, G. E., & Wilke, L. G. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.06.001 · Cited by 37 · see citing works
Self-citationEvaluation of the candidate with a previous malignancy.
Penn, I. (1996) · PubMed · Cited by 30 · see citing works
Soubani, A. O., KANITKAR, A. A., Schwartz, A. G., & George, J. (2018) · Annals of Thoracic Medicine · doi:10.4103/atm.atm_243_17 · Cited by 30 · see citing works
Gin, G. E., Pereira, J. F., Weinberg, A. D., Mehrazin, R., Lerner, S., Sfakianos, J. P., & Phillips, C. K. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.08.020 · Cited by 29 · see citing works
Time to death in breast cancer patients as an indicator of treatment response
Narod, S. A., Giannakeas, V., & Sopik, V. (2018) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-4935-3 · Cited by 29 · see citing works
Schmitges, J., Trinh, Q., Sun, M., et al. (2012) · British Journal of Urology · doi:10.1111/j.1464-410x.2012.10936.x · Cited by 26 · see citing works
Panchabhai, T. S., Arrossi, A. V., Patil, P. D., et al. (2018) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.12.024 · Cited by 26 · see citing works
Bahouth, Z., Halachmi, S., Meyer, G., et al. (2015) · Advances in Urology · doi:10.1155/2015/692014 · Cited by 22 · see citing works
Prostate Cancer in Renal Transplant Recipients: Diagnosis and Treatment
Carvalho, J., Nunes, P., Dinis, P. J., Antunes, H., Parada, B., Marconi, L. S., Moreira, P., Roseiro, A., Bastos, C., Rolo, F., et al. (2017) · Transplantation Proceedings · doi:10.1016/j.transproceed.2017.03.006 · Cited by 22 · see citing works
van der Zanden, L. F. M., Vermeulen, S. H. H. M., Óskarsdóttir, A., et al. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.03.009 · Cited by 19 · see citing works
Low-risk Prostate Cancer Prior to or After Kidney Transplantation
Stöckle, M., Junker, K., & Fornara, P. (2018) · European Urology Focus · doi:10.1016/j.euf.2018.07.003 · Cited by 19 · see citing works
Human papillomavirus, radiation dose and survival of patients with anal cancer
Kabarriti, R., Brodin, N. P., Ohri, N., et al. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1634834 · Cited by 10 · see citing works
Beksac, A. T., Paulucci, D. J., Sfakianos, J. P., et al. (2017) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2017.03.012 · Cited by 8 · see citing works
Contemporary Approaches to High-risk, Early-Stage Serous Endometrial Cancer
Bandera, C., & Dizon, D. S. (2018) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000475 · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821 · see citing works
“Malignancy with high risk of recurrence or death is an absolute contraindication, but it is increasingly acknowledged in the context of lung transplant that not all neoplastic diseases are equal.(13,14) Certain malignancies may not be significantly affected by immunosuppression and some may be managed post-transplant…”
BackgroundIndications for Lung Transplantation and Patient Selection
Son, J., & Shin, C. (2022) · Journal of Chest Surgery · doi:10.5090/jcs.22.057 · Cited by 9 · see citing works
“However, transplantation should be avoided if a metastatic lesion is present, there is a high risk of recurrence, or the patient’s life expectancy is short [6,7].”
Background
- Authors
- Al-Adra, D. P., Hammel, L., Roberts, J., Woodle, E. S., Levine, D., Mandelbrot, D., Verna, E., Locke, J., D’Cunha, J., Farr, M., Sawinski, D., Agarwal, P. K., Plichta, J., Pruthi, S., Farr, D., Carvajal, R., Walker, J., Zwald, F., Habermann, T., Gertz, M., Bierman, P., Dizon, D. S., Langstraat, C., Al-Qaoud, T., Eggener, S., Richgels, J. P., Chang, G. J., Geltzeiler, C., Sapisochin, G., Ricciardi, R., Krupnick, A. S., Kennedy, C., Mohindra, N., Foley, D. P., & Watt, K. D.
- Affiliations
- University of Wisconsin–Madison (US)
- University of California, San Francisco (US)
- University of Cincinnati (US)
- The University of Texas at San Antonio Health Science Center (US)
- University of Alabama at Birmingham (US)
- Mayo Clinic (US)
- University of Pennsylvania (US)
- University of Chicago (US)
- Duke University (US)
- The University of Texas Southwestern Medical Center (US)
- University of Alberta (CA)
- Piedmont Atlanta Hospital (US)
- University of Nebraska Medical Center (US)
- Brown University (US)
- The University of Texas MD Anderson Cancer Center (US)
- Massachusetts General Hospital (US)
- University of Virginia (US)
- Northwestern University (US)
- Corresponding author
- Watt, Kymberly D.
- ORCID
- Al-Adra, David P.
- Roberts, John
- Woodle, E. Steve
- Levine, Deborah
- Mandelbrot, Didier
- Verna, Elizabeth
- Locke, Jayme
- Farr, Maryjane
- Sawinski, Deirdre
- Agarwal, Piyush K.
- Plichta, Jennifer
- Pruthi, Sandhya
- Farr, Deborah
- Carvajal, Richard
- Walker, John
- Zwald, Fiona
- Habermann, Thomas
- Gertz, Morie
- Dizon, Don S.
- Langstraat, Carrie
- Al-Qaoud, Talal
- Eggener, Scott
- Chang, George J.
- Geltzeiler, Cristina
- Ricciardi, Rocco
- Krupnick, Alexander S.
- Kennedy, Cassie
- Mohindra, Nisha
- Foley, David P.
- Watt, Kymberly D.
- Venue
- American Journal of Transplantation
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 21
- Issue
- 2
- Pages
- 460-474
- ISSN
- 1600-6135 (ISSN-L)
- PMC
- PMC8576374
- OpenAlex
- W3088257825
- Cited by
- 163
- References
- 96
- Citations by year
- 2026: 26 · 2025: 39 · 2024: 29 · 2023: 30 · 2022: 17 · 2021: 19 · 2020: 3
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- American Journal of Transplantation (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Transplantation › Organ and Tissue Transplantation Research
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- solid organ transplantation, transplant eligibility, tumor recurrence, immunosuppression, tumor staging, prognosis, breast cancer, colorectal cancer, anal cancer, genitourinary cancer, gynecologic cancer, non-small cell lung cancer, cancer therapy
- MeSH terms
- Humans, Neoplasm Recurrence, Local, Prognosis, Organ Transplantation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
